About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Houston | 156 Studies

Clinical Trials Alzheimer's DiseaseHouston

Alzheimer's Disease Clinical Trials in Houston

Find 156 clinical trials for alzheimer's disease near Houston, Texas. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 156 trials

TerminatedA Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseThe primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the…NCT05310071·Gilbert, Arizona and 264 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPTI-125 for Mild-to-moderate Alzheimer's Disease PatientsThis is a Phase 2b, Randomized, Double-blind, Placebo-controlled, multiple dose study of PTI-125 in mild-to-moderate Alzheimer's disease patients.NCT04079803·Gilbert, Arizona and 8 others

CompletedEffect of Testosterone Therapy in Men With Alzheimer's Disease and Low TestosteroneTreatment with testosterone can improve performance on tests of spatial ability in men with low testosterone levels and Alzheimer's disease.NCT00392912·Houston, Texas

CompletedLong-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseTo evaluate the long-term safety and tolerability of idalopirdine (Lu AE58054) as adjunctive therapy to donepezil in patients with mild-moderate Alzheimer's Disease (AD).NCT02079246·Birmingham, Alabama and 257 others

CompletedLow Dose IL2 Immunotherapy in ADNeuroinflammation is a significant component of Alzheimer disease (AD).NCT05821153·Houston, Texas

Enrolling by invitationAlzheimer's Disease Neuroimaging Initiative 4The Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomized, longitudinal, natural history study designed to validate biomarkers, improve clinical trial design…NCT05617014·Birmingham, Alabama and 64 others

RecruitingA Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule…NCT06937229·Chandler, Arizona and 251 others

RecruitingA Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseaseThe purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.NCT07011745·Chandler, Arizona and 142 others

UnknownEvaluation of 3APS in Patients With Mild to Moderate Alzheimer's DiseaseThe purpose of this Phase III study is to evaluate the efficacy and safety of 3APS compared to placebo (inactive substance pill) in patients with mild to moderate Alzheimer's…NCT00088673·Peoria, Arizona and 66 others

CompletedStudy Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's DiseaseThe purpose of the study is to determine the safety, tolerability, and efficacy of 3 doses of lecozotan in combination with a cholinesterase inhibitor in patients with mild to…NCT00277810·Phoenix, Arizona and 82 others

CompletedSafety and Efficacy of Tafamidis in Patients With Transthyretin CardiomyopathyThis Phase 3 study will investigate the efficacy, safety and tolerability of an oral daily dose of 20 mg or 80 mg tafamidis meglumine capsules compared to placebo in subjects with…NCT01994889·Birmingham, Alabama and 79 others

CompletedA Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)This is a Phase II, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the safety and efficacy of MABT5102A in patients with mild to moderate…NCT01343966·Phoenix, Arizona and 91 others

TerminatedA Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)This randomized, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of crenezumab versus placebo in participants with prodromal to mild…NCT03114657·Scottsdale, Arizona and 210 others

Active not recruitingA Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in…NCT06653153·Birmingham, Alabama and 261 others

Active not recruitingA Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)This study will investigate different donanemab dosing regimens and their effect on the frequency and severity of ARIA-E in adults with early symptomatic Alzheimer's disease (AD)…NCT05738486·Chandler, Arizona and 48 others

CompletedBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)This is a multicenter, double-blind, placebo controlled, randomized, outpatient, multiple dose study in male and female patients ages 50 to less than 89 years with mild to…NCT00575055·Birmingham, Alabama and 185 others

RecruitingScreening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesThis study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.NCT07177352·Birmingham, Alabama and 233 others

UnknownSystemic and Central Inflammation in ADInflammation could provide a new focus for therapeutic intervention.NCT06384378·Houston, Texas

CompletedAn Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's TypeObjectives: The objective of this study will be to determine the safety, tolerability, drug blood levels, and efficacy of each of three doses of NS 2330 (Tesofensine) given once…NCT00153010·Mesa, Arizona and 86 others

WithdrawnSafety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's DiseasePrimary Objective: To compare the effect of repeat doses of Leukine to placebo administered subcutaneously (SC) on established cortical amyloid load in patients with mild…NCT02667496·Houston, Texas

PreviousPage 4 of 8Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia